tm
Seeing Is Believing
tm
Seeing Is Believing
CRDL is currently covered by 2 analysts with an average price target of $6.13. This is a potential upside of $4.72 (334.75%) from yesterday's end of day stock price of $1.41.
Cardiol Therapeutics's activity chart (see below) currently has 13 price targets and 24 ratings on display. The stock rating distribution of CRDL is 100% BUY.
Highest price target for CRDL is $1, Lowest price target is $1.
Most recent stock forecast was given by BRANDON FOLKES from HC WAINWRIGHT on 10-Feb-2026.
Currently out of the existing stock ratings of CRDL, 7 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jan-2025
1 months 27 days ago
(10-Feb-2026)
0/2 (0%)
$7.56 (525.00%)
Buy Since 14-May-2024
$9
11 months 21 days ago
(16-Apr-2025)
0/5 (0%)
$8.18 (997.56%)
Buy Since 04-Dec-2021
$8
$6.59 (467.38%)
1 years 10 months 14 days ago
(23-May-2024)
0/4 (0%)
$5.77 (258.74%)
Buy Since 18-Dec-2021
$3
$1.59 (112.77%)
2 years 7 months 23 days ago
(14-Aug-2023)
0/2 (0%)
$2.07 (222.58%)
What is CRDL (Cardiol Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CRDL (Cardiol Therapeutics) with a proven track record?
Which analyst has the current lower performing score on CRDL (Cardiol Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CRDL (Cardiol Therapeutics)?
Which analyst is the currently most bullish on CRDL (Cardiol Therapeutics)?
Which analyst is the currently most reserved on CRDL (Cardiol Therapeutics)?
